Jahangard 2012.
Study characteristics | ||
Methods | 4‐week trial with 2 arms
Duration of trial: 4 weeks Country: Iran Setting: inpatient |
|
Participants |
Method of recruitment of participants: inpatients at the Farshchian Psychiatric Center of Hamadan were approached.
Sample size: 30 Diagnosis of borderline personality disorder: evaluated with Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM‐IV) Means of assessment: Millon Clinical Multiaxial Inventory, 3rd edition (MCMI‐III) and a score on the subscale “Personality Disorders” of the MCMI‐III of at least 84. Base rate (cut‐off score) on the Hamilton Depression Rating Scale Mean age: 24.63 years (range = 18‐35) Sex: 53% female Comorbidity: generalised anxiety disorder (GAD), post‐traumatic stress disorder (PTSD), current substance dependence, and other affective disorders Inclusion criteria
Exclusion criteria
|
|
Interventions |
Experimental group
Treatment name: emotional intelligence training
Number randomised to group: 15
Duration: 4 weeks, at least 3 sessions (45‐minute/session) per week
Concomitant psychotherapy: not stated
Concomitant pharmacotherapy: at baseline, all had antidepressants (SSRI), and 8/15 had benzodiazepines Control/comparison group Comparison name: control group Number randomised to group: 15 Duration: 4 weeks Concomitant psychotherapy: no psychoeducation, and no instructions in improving emotional intelligence or other interventions, which might be considered as a supportive psychotherapy Concomitant pharmacotherapy: “All patients were pharmacologically treated with SSRIs for depressive disorders, and, if necessary, with benzodiazepines in case of acute sleep difficulties.” (p. 199) At baseline, all had the antidepressants, selective serotonin reuptake Inhibitors (SSRIs). Proportions of participants taking standing psychotropic medication during trial observation period: all took SSRIs, benzodiazepines were taken by 87.5% of the EIT group and 66.7% of the control group (P = 0.44) |
|
Outcomes |
Secondary
|
|
Notes |
Sample size calculation: no
Ethics approval: yes Comments from review authors:
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "We used a simple sample random software: http://www.secutrial.com/blog/2012/05/21/randomisierungen‐in‐ secutrialr/". (Jahangard 2012) [pers comm] |
Allocation concealment (selection bias) | Low risk | Quote: "patients got codes known only to the study supervisor not otherwise involved in the assessment or intervention". (Jahangard 2012) [pers comm] |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Quote: "Raters of the outcome variables were unaware of patients' group allocations".(Jahangard 2012) [pers comm] |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Quote: "All patients sticked on the study conditions, accordingly, we had no missings".(Jahangard 2012) [pers comm] |
Selective reporting (reporting bias) | Unclear risk | Comment: Outcomes were identical in protocol and publication. However, in the protocol primary and secondary outcomes were stated and not in the publication. |
Other bias | Unclear risk |
Treatment adherence: no information on treatment adherence was provided. Allegiance bias: no indication of bias Attention bias: no indication of bias Vested interest: no indication of bias |